{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:10:41Z","timestamp":1762459841816,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["201406002B"],"award-info":[{"award-number":["201406002B"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["15bk0104049h0001"],"award-info":[{"award-number":["15bk0104049h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Transplantation of skeletal myoblast sheets is a promising strategy for the treatment of heart failure, and its therapeutic effects have already been proven in both animal disease models and clinical trials. Myoblast sheets reportedly demonstrate their therapeutic effects by producing many paracrine factors. Although the quality of processed cells for transplantation can be evaluated by the positive ratio of CD56, a myoblast marker, it is unclear which cell populations from isolated cells produce paracrine factors that have an impact on therapeutic effects, and whether these therapeutic effects are closely correlated with CD56-positive cells isolated from the skeletal muscle is also unclear. Therefore, we hypothesized that CD56-negative cells as well as CD56-positive cells isolated from the skeletal muscle produce paracrine factors and have therapeutic effects in skeletal muscle-derived cell sheet therapy for heart failure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Cell surface and intracellular markers of CD56-negative non-myogenic cells (NMCs) and CD56-positive myoblasts were evaluated. We also analyzed cytokine expression, tube formation ability, and stem cell mobilization in both cell populations. Finally, we assessed the therapeutic effects of the cell populations in a rat myocardial infarction model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Analysis of cell surface and intracellular markers revealed that CD56-negative NMCs expressed fibroblast markers and a higher level of mesenchymal cell markers, such as CD49b and CD140a, than myoblasts. Both NMCs and myoblasts expressed various cytokines in vitro with different expression patterns. In addition, NMCs induced tube formation (control vs. myoblasts vs. NMCs: 100\u2009\u00b1\u200911.2 vs. 142\u2009\u00b1\u20098.3 vs. 198\u2009\u00b1\u20097.4%) and stem cell mobilization (control vs. myoblasts vs. NMCs: 100\u2009\u00b1\u20096.8 vs. 210\u2009\u00b1\u200922.9 vs. 351\u2009\u00b1\u200936.0%) to a higher degree in vitro than did myoblasts. The effect of NMCs and myoblasts on the improvement of cardiac function and suppression of myocardial fibrosis in rat myocardial infarction model was comparable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These results indicate that NMCs exhibit therapeutic effects in skeletal muscle-derived cell sheet therapy for heart failure. Thus, accurate parameters correlating with therapeutic effects need to be further explored.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-020-1582-5","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T18:03:01Z","timestamp":1582048981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Role and therapeutic effects of skeletal muscle-derived non-myogenic cells in a rat myocardial infarction model"],"prefix":"10.1186","volume":"11","author":[{"given":"Hiroko","family":"Iseoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akima","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,18]]},"reference":[{"issue":"4","key":"1582_CR1","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/stem.2778","volume":"36","author":"R Wu","year":"2018","unstructured":"Wu R, Hu X, Wang J. Concise review: optimized strategies for stem cell-based therapy in myocardial repair: clinical translatability and potential limitation. Stem Cells. 2018;36(4):482\u2013500.","journal-title":"Stem Cells"},{"issue":"3","key":"1582_CR2","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41587-019-0042-1","volume":"37","author":"KR Chien","year":"2019","unstructured":"Chien KR, Frisen J, Fritsche-Danielson R, Melton DA, Murry CE, Weissman IL. Regenerating the field of cardiovascular cell therapy. Nat Biotechnol. 2019;37(3):232\u20137.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"1582_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/TP.0b013e3181e6f201","volume":"90","author":"S Miyagawa","year":"2010","unstructured":"Miyagawa S, Saito A, Sakaguchi T, Yoshikawa Y, Yamauchi T, Imanishi Y, et al. Impaired myocardium regeneration with skeletal cell sheets--a preclinical trial for tissue-engineered regeneration therapy. Transplantation. 2010;90(4):364\u201372.","journal-title":"Transplantation."},{"issue":"11","key":"1582_CR4","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1097\/TP.0b013e31824fd803","volume":"93","author":"S Saito","year":"2012","unstructured":"Saito S, Miyagawa S, Sakaguchi T, Imanishi Y, Iseoka H, Nishi H, et al. Myoblast sheet can prevent the impairment of cardiac diastolic function and late remodeling after left ventricular restoration in ischemic cardiomyopathy. Transplantation. 2012;93(11):1108\u201315.","journal-title":"Transplantation."},{"issue":"5","key":"1582_CR5","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1253\/circj.CJ-15-0243","volume":"79","author":"Y Sawa","year":"2015","unstructured":"Sawa Y, Yoshikawa Y, Toda K, Fukushima S, Yamazaki K, Ono M, et al. Safety and efficacy of autologous skeletal myoblast sheets (TCD-51073) for the treatment of severe chronic heart failure due to ischemic heart disease. Circ J. 2015;79(5):991\u20139.","journal-title":"Circ J"},{"issue":"7","key":"1582_CR6","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/ehjci\/jey064","volume":"19","author":"S Yoshida","year":"2018","unstructured":"Yoshida S, Miyagawa S, Toda K, Domae K, Sawa Y. Skeletal myoblast sheet transplantation enhanced regional improvement of cardiac function. Eur Heart J Cardiovasc Imaging. 2018;19(7):828\u20139.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"5","key":"1582_CR7","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jtcvs.2005.07.023","volume":"130","author":"IA Memon","year":"2005","unstructured":"Memon IA, Sawa Y, Fukushima N, Matsumiya G, Miyagawa S, Taketani S, et al. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J Thorac Cardiovasc Surg. 2005;130(5):1333\u201341.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"1582_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3727\/096368915X688254","volume":"25","author":"A Siltanen","year":"2016","unstructured":"Siltanen A, Nuutila K, Imanishi Y, Uenaka H, Makela J, Patila T, et al. The paracrine effect of skeletal myoblasts is cardioprotective against oxidative stress and involves EGFR-ErbB4 signaling, cystathionase, and the unfolded protein response. Cell Transplant. 2016;25(1):55\u201369.","journal-title":"Cell Transplant"},{"key":"1582_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13287-015-0063-8","volume":"6","author":"M Kozakowska","year":"2015","unstructured":"Kozakowska M, Kotlinowski J, Grochot-Przeczek A, Ciesla M, Pilecki B, Derlacz R, et al. Myoblast-conditioned media improve regeneration and revascularization of ischemic muscles in diabetic mice. Stem Cell Res Ther. 2015;6:61.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"1582_CR10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/mt.2014.225","volume":"23","author":"S Kainuma","year":"2015","unstructured":"Kainuma S, Miyagawa S, Fukushima S, Pearson J, Chen YC, Saito A, et al. Cell-sheet therapy with omentopexy promotes arteriogenesis and improves coronary circulation physiology in failing heart. Mol Ther. 2015;23(2):374\u201386.","journal-title":"Mol Ther"},{"issue":"1","key":"1582_CR11","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1038\/s41598-017-05099-1","volume":"7","author":"EG Suto","year":"2017","unstructured":"Suto EG, Mabuchi Y, Suzuki N, Suzuki K, Ogata Y, Taguchi M, et al. Prospectively isolated mesenchymal stem\/stromal cells are enriched in the CD73(+) population and exhibit efficacy after transplantation. Sci Rep. 2017;7(1):4838.","journal-title":"Sci Rep"},{"issue":"1","key":"1582_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1152\/physrev.00019.2003","volume":"84","author":"SB Charge","year":"2004","unstructured":"Charge SB, Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev. 2004;84(1):209\u201338.","journal-title":"Physiol Rev"},{"issue":"13","key":"1582_CR13","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1101\/gad.1419406","volume":"20","author":"X Shi","year":"2006","unstructured":"Shi X, Garry DJ. Muscle stem cells in development, regeneration, and disease. Genes Dev. 2006;20(13):1692\u2013708.","journal-title":"Genes Dev"},{"issue":"1","key":"1582_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/jcp.10322","volume":"196","author":"JD Stewart","year":"2003","unstructured":"Stewart JD, Masi TL, Cumming AE, Molnar GM, Wentworth BM, Sampath K, et al. Characterization of proliferating human skeletal muscle-derived cells in vitro: differential modulation of myoblast markers by TGF-beta2. J Cell Physiol. 2003;196(1):70\u20138.","journal-title":"J Cell Physiol"},{"issue":"9","key":"1582_CR15","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/nbt1334","volume":"25","author":"B Zheng","year":"2007","unstructured":"Zheng B, Cao B, Crisan M, Sun B, Li G, Logar A, et al. Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol. 2007;25(9):1025\u201334.","journal-title":"Nat Biotechnol"},{"doi-asserted-by":"publisher","unstructured":"Miyagawa S, Domae K, Yoshikawa Y, Fukushima S, Nakamura T, Saito A, et al. Phase I clinical trial of autologous stem cell-sheet transplantation therapy for treating cardiomyopathy. J Am Heart Assoc. 2017;6(4):e003918.\u00a0https:\/\/doi.org\/10.1161\/JAHA.116.003918.","key":"1582_CR16","DOI":"10.1161\/JAHA.116.003918"},{"issue":"3\u20134","key":"1582_CR17","first-page":"728","volume":"20","author":"Y Shudo","year":"2014","unstructured":"Shudo Y, Miyagawa S, Ohkura H, Fukushima S, Saito A, Shiozaki M, et al. Addition of mesenchymal stem cells enhances the therapeutic effects of skeletal myoblast cell-sheet transplantation in a rat ischemic cardiomyopathy model. Tissue Eng Part A. 2014;20(3\u20134):728\u201339.","journal-title":"Tissue Eng Part A"},{"issue":"2","key":"1582_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.stemcr.2016.07.004","volume":"7","author":"A Uezumi","year":"2016","unstructured":"Uezumi A, Nakatani M, Ikemoto-Uezumi M, Yamamoto N, Morita M, Yamaguchi A, et al. Cell-surface protein profiling identifies distinctive markers of progenitor cells in human skeletal muscle. Stem Cell Rep. 2016;7(2):263\u201378.","journal-title":"Stem Cell Rep"},{"key":"1582_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-1-4939-3810-0_17","volume":"1460","author":"A Uezumi","year":"2016","unstructured":"Uezumi A, Kasai T, Tsuchida K. Identification, isolation, and characterization of mesenchymal progenitors in mouse and human skeletal muscle. Methods Mol Biol. 2016;1460:241\u201353.","journal-title":"Methods Mol Biol"},{"issue":"3","key":"1582_CR20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/ncb3475","volume":"19","author":"N Asada","year":"2017","unstructured":"Asada N, Kunisaki Y, Pierce H, Wang Z, Fernandez NF, Birbrair A, et al. Differential cytokine contributions of perivascular haematopoietic stem cell niches. Nat Cell Biol. 2017;19(3):214\u201323.","journal-title":"Nat Cell Biol"},{"issue":"7440","key":"1582_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature11926","volume":"495","author":"A Greenbaum","year":"2013","unstructured":"Greenbaum A, Hsu YM, Day RB, Schuettpelz LG, Christopher MJ, Borgerding JN, et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature. 2013;495(7440):227\u201330.","journal-title":"Nature."},{"issue":"7","key":"1582_CR22","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1161\/CIRCRESAHA.116.309819","volume":"120","author":"AJ Kanelidis","year":"2017","unstructured":"Kanelidis AJ, Premer C, Lopez J, Balkan W, Hare JM. Route of delivery modulates the efficacy of mesenchymal stem cell therapy for myocardial infarction: a meta-analysis of preclinical studies and clinical trials. Circ Res. 2017;120(7):1139\u201350.","journal-title":"Circ Res"},{"issue":"1","key":"1582_CR23","doi-asserted-by":"publisher","first-page":"9448","DOI":"10.1038\/s41598-018-27881-5","volume":"8","author":"K Kobayashi","year":"2018","unstructured":"Kobayashi K, Ichihara Y, Tano N, Fields L, Murugesu N, Ito T, et al. Fibrin glue-aided, instant epicardial placement enhances the efficacy of mesenchymal stromal cell-based therapy for heart failure. Sci Rep. 2018;8(1):9448.","journal-title":"Sci Rep"},{"issue":"6","key":"1582_CR24","doi-asserted-by":"publisher","first-page":"e0127302","DOI":"10.1371\/journal.pone.0127302","volume":"10","author":"A Toyoshima","year":"2015","unstructured":"Toyoshima A, Yasuhara T, Kameda M, Morimoto J, Takeuchi H, Wang F, et al. Intra-arterial transplantation of allogeneic mesenchymal stem cells mounts neuroprotective effects in a transient ischemic stroke model in rats: analyses of therapeutic time window and its mechanisms. PLoS One. 2015;10(6):e0127302.","journal-title":"PLoS One"},{"issue":"5","key":"1582_CR25","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1161\/STROKEAHA.111.000326","volume":"44","author":"CT van Velthoven","year":"2013","unstructured":"van Velthoven CT, Sheldon RA, Kavelaars A, Derugin N, Vexler ZS, Willemen HL, et al. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke. 2013;44(5):1426\u201332.","journal-title":"Stroke."},{"key":"1582_CR26","first-page":"2667","volume":"6","author":"ZM Binsalamah","year":"2011","unstructured":"Binsalamah ZM, Paul A, Khan AA, Prakash S, Shum-Tim D. Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model. Int J Nanomedicine. 2011;6:2667\u201378.","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"1582_CR27","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.yjmcc.2010.03.008","volume":"48","author":"M Vantler","year":"2010","unstructured":"Vantler M, Karikkineth BC, Naito H, Tiburcy M, Didie M, Nose M, et al. PDGF-BB protects cardiomyocytes from apoptosis and improves contractile function of engineered heart tissue. J Mol Cell Cardiol. 2010;48(6):1316\u201323.","journal-title":"J Mol Cell Cardiol"},{"issue":"18","key":"1582_CR28","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.jacc.2015.08.879","volume":"66","author":"V Karantalis","year":"2015","unstructured":"Karantalis V, Suncion-Loescher VY, Bagno L, Golpanian S, Wolf A, Sanina C, et al. Synergistic effects of combined cell therapy for chronic ischemic cardiomyopathy. J Am Coll Cardiol. 2015;66(18):1990\u20139.","journal-title":"J Am Coll Cardiol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-1582-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-020-1582-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-1582-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T08:00:31Z","timestamp":1613808031000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-1582-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,18]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1582"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-1582-5","relation":{},"ISSN":["1757-6512"],"issn-type":[{"type":"electronic","value":"1757-6512"}],"subject":[],"published":{"date-parts":[[2020,2,18]]},"assertion":[{"value":"17 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The handling of human tissue was approved by the Ethics Committee of Osaka University Graduate School of Medicine and informed, written consent was obtained from all donors. The Institutional Ethics Review Committee for Animal Experimentation approved all animal experimental study protocols.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}